Department of Cardiac and Vascular Diseases, John Paul II Hospital in Krakow, Krakow, 31-202, Poland.
Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Faculty of Medicine, Jagiellonian University Medical College, Krakow, 31-008, Poland.
Cardiovasc Diabetol. 2023 Jul 13;22(1):177. doi: 10.1186/s12933-023-01885-6.
Recent studies revealed that alterations in glucose and lipid metabolism in idiopathic pulmonary arterial hypertension (IPAH) are associated with disease severity and poor survival. However, data regarding the impact of diabetes mellitus (DM) on the prognosis of patients with IPAH remain scarce. The aim of our study was to determine that impact using data from a national multicentre prospective pulmonary hypertension registry.
We analysed data of adult patients with IPAH from the Database of Pulmonary Hypertension in the Polish population (BNP‑PL) between March 1, 2018 and August 31, 2020. Upon admission, clinical, echocardiographic, and haemodynamic data were collected at 21 Polish IPAH reference centres. The all-cause mortality was assessed during a 30-month follow-up period. To adjust for differences in age, body mass index (BMI), and comorbidities between patients with and without DM, a 2-group propensity score matching was performed using a 1:1 pairing algorithm.
A total of 532 patients with IPAH were included in the study and 25.6% were diagnosed with DM. Further matched analysis was performed in 136 patients with DM and 136 without DM. DM was associated with older age, higher BMI, more advanced exertional dyspnea, increased levels of N-terminal pro-brain natriuretic peptide, larger right atrial area, increased mean right atrial pressure, mean pulmonary artery pressure, pulmonary vascular resistance, and all-cause mortality compared with no DM.
Patients with IPAH and DM present with more advanced pulmonary vascular disease and worse survival than counterparts without DM independently of age, BMI, and cardiovascular comorbidities.
最近的研究表明,特发性肺动脉高压(IPAH)中葡萄糖和脂质代谢的改变与疾病严重程度和生存预后不良有关。然而,关于糖尿病(DM)对 IPAH 患者预后影响的数据仍然很少。我们的研究目的是使用来自全国多中心前瞻性肺动脉高压登记处的数据来确定这种影响。
我们分析了 2018 年 3 月 1 日至 2020 年 8 月 31 日期间波兰人群肺动脉高压数据库(BNP-PL)中成年 IPAH 患者的数据。在 21 个波兰 IPAH 参考中心收集了入院时的临床、超声心动图和血流动力学数据。在 30 个月的随访期间评估全因死亡率。为了调整 DM 患者和非 DM 患者之间的年龄、体重指数(BMI)和合并症差异,使用 1:1 配对算法进行了 2 组倾向评分匹配。
共纳入 532 例 IPAH 患者,其中 25.6%被诊断为 DM。进一步在 136 例 DM 患者和 136 例非 DM 患者中进行了匹配分析。与非 DM 患者相比,DM 患者年龄较大、BMI 较高、运动性呼吸困难更严重、N 端脑利钠肽前体水平升高、右心房面积更大、平均右心房压、平均肺动脉压、肺血管阻力均升高,全因死亡率更高。
与无 DM 的 IPAH 患者相比,有 DM 的 IPAH 患者的肺血管疾病更严重,生存预后更差,与年龄、BMI 和心血管合并症无关。